BeOne Medicines Ltd. Proceeds from Stock Issuance 2015-2023 | ONC

Beta

What is BeOne Medicines Ltd.'s current proceeds from stock issuance?

BeOne Medicines Ltd. (ONC) annual proceeds from stock issuance for 2023 was $0, a NaN% decline from 2022. BeOne Medicines Ltd. proceeds from stock issuance for the quarter ending September 30, 2022 was $0.

What was BeOne Medicines Ltd.'s proceeds from stock issuance in 2022?

BeOne Medicines Ltd. annual proceeds from stock issuance for 2022 was $0, a 100.00% decline from 2021.

What was BeOne Medicines Ltd.'s proceeds from stock issuance in 2021?

BeOne Medicines Ltd. annual proceeds from stock issuance for 2021 was $50.0M, a 98.82% decline from 2020.

Proceeds from Stock Issuance History

Year-over-year comparison from 10-K annual reports

Key Statistics

Trend Direction

Stable

CAGRN/A

FY2018

$29.7M

→

FY2023

151617181920212223

5 years selected

Proceeds from Stock Issuance History

Period	Value	Change	Source
FY2023	$0	-	10-K
FY2022	$0	-100.0%	10-K
FY2021	$50.0M	-98.8%	10-K
FY2020	$4.23B	+8903.5%	10-K
FY2019	$47.0M	+58.5%	10-K
FY2018	$29.7M	+541.1%	10-K
FY2017	$4.6M	+5683.8%	10-K
FY2016	$80,000	+3.9%	10-K
FY2015	$77,000	-	10-K

Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →